Clinical trial
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone…
NCT00176280 · University of Kentucky, Other · Withdrawn
Key facts
| NCT number | NCT00176280 |
|---|---|
| Title | Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma |
| Official title | A Randomized Phase II Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemcitabine and 5-Fluorouracil (5-FU) in Patients With Metastatic Renal Cell Carcinoma (RCC) |
| Lead sponsor | University of Kentucky, Other |
| Collaborators | Bayer Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Cell Carcinoma |
| Intervention type | Drug |
| Interventions | Leukine, Dexamethasone |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 18, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: